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Abstract
We report here on the primary structure and functional characteristics of the protein responsible for the system A amino
acid transport activity that is known to be expressed in most human tissues. This transporter, designated ATA2 for amino
acid transporter A2, was cloned from the human hepatoma cell line HepG2. Human ATA2 (hATA2) consists of 506 amino
acids and exhibits a high degree of homology to rat ATA2. hATA2-specific mRNA is ubiquitously expressed in human
tissues. When expressed in mammalian cells, hATA2 mediates Na-dependent transport of K-(methylamino)isobutyric acid,
a specific model substrate for system A. The transporter is specific for neutral amino acids. It is pH-sensitive and Li-
intolerant. The Na :amino acid stoichiometry is 1:1. ß 2000 Elsevier Science B.V. All rights reserved.
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System A was one of the ¢rst amino acid transport
systems to be described in mammalian cells [1,2]. The
expression of transport system is widespread in mam-
malian tissues [3^5]. The unique characteristics of
system A include the absolute requirement for Na
for transport activity, preference for short-chain neu-
tral amino acids as substrates, stimulation of trans-
port activity by alkaline pH of the extracellular me-
dium and inhibition of transport activity by system
A substrates on the trans side. K-(Methylamino)iso-
butyric acid (MeAIB) is considered the model sub-
strate for system A. Na-dependent transport of
MeAIB is usually taken as the functional activity
mediated speci¢cally by system A. An important fea-
ture of system A is its regulatory characteristics [6^8].
A variety of hormones, growth factors and mitogens
are known to modulate the expression of this trans-
porter in di¡erent organs including liver, adipose tis-
sue, and skeletal muscle. In addition, physiological
conditions such as starvation and pregnancy and
pathological conditions such as diabetes have been
shown to be associated with alterations in the trans-
port activity of system A in di¡erent organs. Re-
cently, we reported on the cloning of the protein
from rat skeletal muscle that is responsible for sys-
tem A activity in most tissues [9]. This protein, des-
ignated ATA2 for amino acid transporter A2, bears
signi¢cant homology to the recently cloned rat glu-
tamine transporter (GlnT) [10]. Since GlnT is capa-
ble of mediating Na-dependent transport of the sys-
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tem A-speci¢c model substrate MeAIB, this trans-
porter must be a subtype of system A. Therefore,
we identify GlnT as ATA1 in this paper. Another
transporter that shows signi¢cant similarity in amino
acid sequence to ATA1 and ATA2 is the amino acid
transport system N (SN1) [11]. These three amino
acid transporters constitute the members of a gene
family that is distinct from the previously known
amino acid transporter gene families [12^14]. To
date, ATA1, ATA2 and SN1 have been cloned
only from rat or mouse tissues [9^11,15]. There
have been no reports on the cloning of the human
homolog of any of these three amino acid transport-
ers. Here we report on the cloning of human ATA2,
the ¢rst human homolog to be characterized at the
structural and functional level that belongs to this
most recently identi¢ed amino acid transporter gene
family. We cloned this transporter (human ATA2)
from a HepG2 human hepatoma cell line cDNA li-
brary. The cloned transporter is able to mediate the
Na-dependent transport of MeAIB. The transport
function is pH-sensitive, Li-intolerant, and is specif-
ic for short-chain neutral amino acids.
[14C]MeAIB (speci¢c radioactivity, 50 mCi/mmol)
was purchased from American Radiolabeled Chem-
icals (St. Louis, MO, USA). Human retinal pigment
epithelial (HRPE) cells were originally provided by
Dr. Del Monte (University of Michigan, Ann Arbor,
MI, USA) and have been in use in our laboratory for
several years for heterologous expression of a variety
of cloned transporters [16^18]. Cell culture media,
TRIzol reagent, oligo(dT)-cellulose, and Lipofectin
were from Life Technologies (Gaithersburg, MD,
USA). Restriction enzymes were either from Prome-
ga or from New England Biolabs. Magna nylon
transfer membranes used in the library screening
were from Micron Separations, Inc. (Westboro,
MA, USA).
The SuperScript plasmid system (Life Technolo-
gies, Rockville, MD, USA) was used to establish a
unidirectional cDNA library with poly(A) mRNA
isolated from HepG2 cells (a human hepatoma cell
line). Poly(A) mRNA was prepared by subjecting
total RNA twice to oligo(dT)-cellulose a⁄nity chro-
matography prior to use in library construction. The
cDNA products with sizes greater than 1 kb were
separated by size fractionation and used for ligation
at SalI/NotI site in pSPORT1 vector.
A cDNA fragment of the recently cloned rat
ATA2 [9] was used as the probe in the screening of
the HepG2 cDNA library. HepG2 cDNA library was
screened under low stringency conditions as de-
scribed previously [16^18] using the rat ATA2-specif-
ic cDNA fragment as the probe. Positive clones were
identi¢ed, and the colonies were puri¢ed by second-
ary screening. Both sense and antisense strands of
the cDNA were sequenced using an automated Per-
kin-Elmer Applied Biosystems 377 Prism DNA se-
quencer. The sequence was analyzed using the
GCG sequence analysis software package GCG ver-
sion 10 (Genetics Computer Group, Inc., Madison,
WI, USA).
The functional expression of the cloned human
ATA2 cDNA was done in HRPE cells using the
vaccinia virus expression system as described previ-
ously [16^18]. Transport measurements were made at
37‡C for 15 min with [14C]MeAIB as the substrate.
The transport bu¡er was 25 mM Tris/HEPES (pH
8.0), containing 140 mM NaCl, 5.4 mM KCl, 1.8
mM CaCl2, 0.8 mM MgSO4, and 5 mM glucose.
Endogenous transport was always determined in par-
allel using cells transfected with vector alone. This
transport accounted for 6 10% of the transport mea-
sured in cells that were transfected with the cDNA.
cDNA-speci¢c transport was calculated by adjusting
for the endogenous activity. The kinetic parameters,
Michaelis^Menten constant (Kt) and maximal veloc-
ity (Vmax), were calculated by ¢tting the cDNA-spe-
ci¢c transport data to the Michaelis^Menten equa-
tion describing a single saturable transport system.
Analysis was done by non-linear regression and the
resultant values for the kinetic parameters were con-
¢rmed by linear regression. Na activation kinetics
were analyzed by ¢tting the cDNA-speci¢c transport
data to the Hill equation and the Hill coe⁄cient was
calculated by non-linear regression as well as by lin-
ear regression.
A commercially available human multiple tissue
blot (Origene, Rockville, MD, USA) was used to
determine the tissue expression pattern of the cloned
transporter. The blot was hybridized under high
stringency conditions with the cloned cDNA as the
probe.
Screening of the HepG2 cDNA library with the rat
ATA2-speci¢c cDNA probe resulted in the identi¢-
cation of a clone that was able to induce Na-depen-
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dent transport of MeAIB in HRPE cells (see below).
Human ATA2 cDNA is 4479 bp long (GenBank
accession number AF259799) and encodes a protein
of 506 amino acids (Fig. 1). At the level of amino
acid sequence, human ATA2 exhibits a high degree
of homology to rat ATA2 (88% identity; 93% sim-
ilarity). Rat ATA2 consists of 504 amino acids, two
amino acids shorter than human ATA2. The extra
two amino acids in human ATA2 are located in the
sixth transmembrane domain. Except for this subtle
di¡erence, the predicted topology of human ATA2 is
highly comparable to that of rat ATA2. Hydropathy
analysis indicates that human as well as rat ATA2
possess 12 putative transmembrane domains.
The tissue distribution pattern of ATA2 mRNA in
the human was studied by Northern blot (Fig. 2). All
12 tissues tested (brain, colon, heart, kidney, liver,
lung, muscle, placenta, small intestine, spleen, stom-
ach, and testis) were positive for ATA2 mRNA. The
size of the hybridization-positive band was 4.5 kb.
The hybridization signal was the weakest in colon
and small intestine, but was easily detectable upon
longer exposure of the autoradiogram. There was a
Fig. 1. Primary structure of human ATA2. The amino acid sequence of human ATA2 (hATA2) is compared with that of rat ATA2
(rATA2). The regions of sequence conservation between the two proteins are boxed.
Fig. 2. Northern blot analysis of ATA2-speci¢c mRNA in hu-
man tissues.
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minor hybridization-positive band of 9 kb in size
that was expressed primarily in the placenta and
heart. This band was the result of a weak cross-hy-
bridization of the ATA2-speci¢c probe with ATA1
mRNA. We have cloned the human homolog of
ATA1 from a human placental cDNA library (un-
published data). Northern blot analysis of the same
human multiple tissue blot with an ATA1-speci¢c
cDNA probe has revealed the presence of a hybrid-
ization-positive band of 9 kb in size in placenta and
heart. In addition, there was a minor hybridization-
positive band of 4.5 kb in size in most tissues. This
minor band was the result of a weak cross-hybridi-
zation of the ATA1-speci¢c probe with ATA2
mRNA (unpublished data). This cross-hybridization
was noted in spite of the use of high stringency con-
ditions for the Northern blot analysis, indicating a
high degree of homology between the two mRNA
species at the nucleotide level.
Heterologous expression of human ATA2 in
HRPE cells using the vaccinia virus expression tech-
nique led to the induction of MeAIB transport (Fig.
3A). Transport of MeAIB in the presence of NaCl
was 11-fold higher in human ATA2 cDNA-trans-
fected cells than in vector-transfected cells. The
cDNA-speci¢c transport was obligatorily dependent
on the presence of Na since replacement of Na
Fig. 3. (A) Ionic requirements of human ATA2 (hATA2).
Transport of [14C]MeAIB (16 WM) was measured in vector-
transfected cells (open bar) and hATA2 cDNA-transfected cells
(solid bar) at 37‡C for 15 min in the presence of NaCl, sodium
gluconate, NMDG chloride or LiCl under isoosmotic condi-
tions. The pH of the transport bu¡er was 8.0 in all cases. Val-
ues are means þ S.E.M. from three determinations. (B) pH de-
pendence of the transport function of hATA2. Transport of
[14C]MeAIB (16 WM) was measured in vector-transfected cells
(a) and hATA2 cDNA-transfected cells (b) at 37‡C for 15 min
in the presence of NaCl. The pH of the transport bu¡er was
varied by appropriately adjusting the concentrations of MES,
HEPES, and Tris. Values are means þ S.E.M. from three deter-
minations.
Table 1
Substrate speci¢city of human ATA2
Unlabeled amino
acid
cDNA-speci¢c [14C]MeAIB transport in
HRPE cells (pmol/106 cells/15 min)
Control 2631 þ 251 (100)
MeAIB 290 þ 7 (11)
Alanine 291 þ 28 (11)
Glycine 678 þ 124 (26)
Serine 578 þ 68 (22)
Proline 638 þ 60 (24)
Methionine 308 þ 34 (12)
Asparagine 490 þ 62 (19)
Glutamine 503 þ 78 (19)
Threonine 862 þ 73 (33)
Leucine 906 þ 98 (34)
Phenylalanine 1325 þ 203 (50)
Tryptophan 2696 þ 101 (102)
Arginine 3111 þ 428 (118)
Lysine 2429 þ 235 (92)
Aspartic acid 3010 þ 224 (114)
Glutamic acid 2508 þ 222 (95)
HRPE cells were transfected with either pSPORT alone or
pSPORT-human ATA2 cDNA. Transport of [14C]MeAIB (16
WM) was measured in these cells at 37‡C for 15 min in the
presence of NaCl (pH 8.0). When present, the concentration of
unlabeled amino acids was 5 mM. cDNA-speci¢c [14C]MeAIB
transport was calculated by subtracting the transport in vector-
transfected cells from the transport in cDNA-transfected cells.
Values in parentheses are percent of control transport measured
in the absence of unlabeled amino acids. Values are means þ
S.E.M. from four determinations.
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with N-methyl-D-glucamine almost completely abol-
ished the transport. The transport process was Li-
intolerant as evidenced from the inability of Li to
substitute e¡ectively for Na. Replacement of Cl3
with gluconate had no e¡ect on the transport, sug-
gesting that Cl3 ions are not involved in the trans-
port process mediated by human ATA2. The trans-
port function of human ATA2 was markedly pH-
sensitive (Fig. 3B). The cDNA-speci¢c transport
was barely detectable at pH 6.0, but it increased
dramatically when the pH was changed from 6.0 to
8.5 and the peak was at pH 8.0. There was a 10-fold
increase in cDNA-speci¢c transport when the pH of
the extracellular medium was changed from 6.0 to
8.0. The cDNA-speci¢c transport of MeAIB was sat-
urable (Fig. 4A) and the transport values were found
to ¢t very well to the Michaelis^Menten equation
describing a single saturable system. The Michaelis^
Menten constant for the transport process was
0.39 þ 0.05 mM. Fig. 4B describes the Na activation
kinetics of human ATA2. The relationship between
cDNA-speci¢c transport of MeAIB and Na concen-
tration was hyperbolic. When analyzed by ¢tting the
data to the Hill equation, a value of 1.03 þ 0.19 was
obtained for the Hill coe⁄cient. The K0:5 (i.e., the
concentration of Na necessary for half-maximal ac-
tivation) was 9.6 þ 1.5 mM. These results show that
the Na :MeAIB stoichiometry for human ATA2 is
1:1.
Competition experiments revealed that human
ATA2 was able to recognize several neutral amino
acids as substrates (Table 1). Alanine, glycine, serine,
proline, methionine, asparagine, glutamine, threonine
and leucine were very e¡ective in competing with
[14C]MeAIB for the transport process mediated by
human ATA2. Phenylalanine was comparatively
less e¡ective. Tryptophan, cationic amino acids (ar-
ginine and lysine), and anionic amino acids (aspar-
tate and glutamate) were very weak in competing
with human ATA2-mediated transport of
[14C]MeAIB.
Functionally, human ATA2 exhibits all of the
characteristics that are known to be associated with
system A in mammalian tissues. This includes the
Na dependence, pH sensitivity, Li intolerance,
and preference for short-chain neutral amino acids
as substrates. There are no notable di¡erences be-
tween human ATA2 and rat ATA2 at the functional
level. One of the important features of system A is
the regulation of its expression in a variety of phys-
iological and pathological conditions. To date, all of
these regulatory studies have been carried out pri-
marily at the phenomenological level. Molecular
studies of the regulation of this transporter have
not been feasible because of the lack of the knowl-
edge on the structure of the protein responsible for
the transport function. The successful cloning of the
rat and human ATA2 cDNAs ([9], present study) is
Fig. 4. (A) Saturation kinetics of MeAIB. Transport of MeAIB
(0.1^5 mM) was measured in vector-transfected cells and hu-
man ATA2 cDNA-transfected cells at 37‡C for 15 min in the
presence of NaCl (pH 8.0). Values (means þ S.E.M.) represent
only the cDNA-speci¢c transport. (Inset) Eadie^Hofstee plot.
(B) Na activation kinetics. Transport of [14C]MeAIB (16 WM)
was measured in vector-transfected cells and human ATA2
cDNA-transfected cells at 37‡C for 15 min. Concentration of
Na in the transport bu¡er (pH 8.0) was varied over the range
of 0^100 mM. Values (means þ S.E.M.) represent only the
cDNA-speci¢c transport. (Inset) Hill plot.
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likely to lead to the generation of system A-speci¢c
cDNA probes and antibodies that can be used in
future investigations of the regulation of the expres-
sion of the transporter at the level of mRNA and
protein.
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